[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342033-105":59,"doc-detail-342033-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","unveiling-the-mechanism-of-compound-ku-shen-injection-in-liver-cancer-treatment-through-an-ingredienttarget-network-analysis","Unveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient–Target Network Analysis","","Compound Ku-Shen Injection (CKI), a traditional Chinese medicine preparation derived from Ku-Shen and Bai-Tu-Ling, is widely used as an adjunct therapy for advanced cancers, including liver cancer, yet its therapeutic mechanism remains insufficiently defined. This study applies network pharmacology to examine TCM compatibility theory, supported by molecular docking and in vitro assays. Sixteen active components and 193 liver-cancer-related targets were identified, with key proteins such as EGFR and ESR1. KEGG enrichment highlighted neuroactive ligand–receptor interaction, cAMP signaling, and serotonergic synapses as major pathways. Docking confirmed binding between key ingredients and core targets. CCK-8 assays showed oxymatrine and matrine inhibit HepG2 cell proliferation, and Western blot demonstrated oxymatrine suppresses EGFR expression, elucidating CKI’s action and compatibility principles.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unveiling-the-mechanism-of-compound-ku-shen-injection-in-liver-cancer-treatment-through-an-ingredienttarget-network-analysis/342033/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unveiling-the-mechanism-of-compound-ku-shen-injection-in-liver-cancer-treatment-through-an-ingredienttarget-network-analysis/342033.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study address about Compound Ku-Shen Injection (CKI)?","Question",{"text":112,"@type":113},"CKI is used as an adjunct for advanced cancers, including liver cancer, but the underlying mechanisms of how it works are not well defined.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study investigate CKI’s mechanism and targets?",{"text":117,"@type":113},"It used network pharmacology to analyze TCM compatibility, then validated findings with molecular docking and in vitro experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"Which targets and signaling pathways were identified as important for CKI’s action in liver cancer?",{"text":121,"@type":113},"Key therapeutic targets included EGFR and ESR1, and KEGG enrichment highlighted neuroactive ligand–receptor interaction, cAMP signaling, and serotonergic synapses as key pathways.",{"name":123,"@type":110,"acceptedAnswer":124},"What experimental evidence supported CKI components’ anti-liver-cancer effects?",{"text":125,"@type":113},"CCK-8 assays showed oxymatrine and matrine inhibited HepG2 cell proliferation, and Western blot indicated oxymatrine reduced EGFR expression.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},342033,1790907365,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nUnveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient–Target Network Analysis  \nWenkui Zou 1, Jiazhen Liu 1, Zexing Wei 2, Chunhua Peng 1, Ying Zhao 1, Yue Ding 1, Jifan Shi 3,4,* and Juan Zhao 1, *  \nCitation: Zou, W.; Liu, J.; Wei, Z.; Peng, C.; Zhao, Y.; Ding, Y.; Shi, J.; Zhao, J. Unveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient–Target Network Analysis. Genes 2024, 15, 1278. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/genes15101278](10.3390/genes15101278)  \nAcademic Editor: Clifford J. Steer  \nReceived: 6 September 2024  \nRevised: 24 September 2024  \nAccepted: 27 September 2024  \nPublished: 29 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  \n2 School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  \n3 Research Institute of Intelligent Complex Systems, Fudan University, Shanghai 200433, China  \n4 Shanghai Artificial Intelligence Laboratory, Shanghai 200232, China  \n* [Correspondence: jfshi@fudan.edu.cn](Correspondence: jfshi@fudan.edu.cn) (J.S.); [zhaojuan@shutcm.edu.cn](zhaojuan@shutcm.edu.cn) (J.Z.); Tel.: +86-21-65676379 (J.S.);+86-21-51322192 (J.Z.)  \nAbstract: Background: Compound Ku-Shen Injection (CKI) is a traditional Chinese medicine preparation derived from Ku-Shen and Bai-Tu-Ling, commonly used in the adjunctive treatment of advanced cancers, including liver cancer. However, the underlying mechanisms of CKI’s effectiveness in cancer treatment are not well defined. Methods: This study employs network pharmacology to investigate the traditional Chinese medicine (TCM) compatibility theory underlying CKI’s action in treating liver cancer, with findings substantiated by molecular docking and in vitro experiments. Sixteen active components were identified from CKI, along with 193 potential targets for treating liver cancer. Key therapeutic target proteins, including EGFR and ESR1, were also identified. KEGG enrichment results showed that the neuroactive ligand–receptor interaction, cAMP signaling pathway, and serotonergic synapses make up the key pathway of CKI in the treatment of liver cancer. Molecular docking results confirmed that the key active ingredients effectively bind to the core targets. CCK-8 cytotoxic experiment results show that the CKI key components of oxymatrine and matrine can inhibit the growth of HepG2 liver cancer cell proliferation. A Western blot analysis revealed that oxymatrine suppresses the expression of EGFR, contributing to its therapeutic efficacy against liver cancer. Conclusion: our study elucidated the therapeutic mechanism of CKI in treating liver cancer and unveiled the underlying principles of its TCM compatibility through its mode of action.  \nKeywords: compound matrine injection; network pharmacology; liver cancer; molecular docking  \n1. Introduction  \nLiver cancer is one of the most common and deadly malignant tumors in modern society, with its incidence increasing annually [1] . Liver cancer is marked by an insidious onset, rapid progression, high malignancy, and significant mortality. Currently, the primary treatments for liver cancer include surgery, chemotherapy, biological therapy, and radiotherapy [2] . Although these treatments can be effective for liver cancer patients, they also carry significant side effects. As research in traditional Chinese medicine (TCM) advances [3], using TCM alone or in combination with anticancer drugs to treat liver cancer has gained i","cbCaipvTmgfccLf3","https://ap.wps.com/l/cbCaipvTmgfccLf3","pdf",5364232,14,"English","# Introduction\n## Background on liver cancer and current therapies\n## CKI in traditional Chinese medicine and its clinical use\n## Challenges in researching CKI mechanisms and study rationale","[{\"question\":\"What clinical problem does the study address about Compound Ku-Shen Injection (CKI)?\",\"answer\":\"CKI is used as an adjunct for advanced cancers, including liver cancer, but the underlying mechanisms of how it works are not well defined.\"},{\"question\":\"How did the study investigate CKI’s mechanism and targets?\",\"answer\":\"It used network pharmacology to analyze TCM compatibility, then validated findings with molecular docking and in vitro experiments.\"},{\"question\":\"Which targets and signaling pathways were identified as important for CKI’s action in liver cancer?\",\"answer\":\"Key therapeutic targets included EGFR and ESR1, and KEGG enrichment highlighted neuroactive ligand–receptor interaction, cAMP signaling, and serotonergic synapses as key pathways.\"},{\"question\":\"What experimental evidence supported CKI components’ anti-liver-cancer effects?\",\"answer\":\"CCK-8 assays showed oxymatrine and matrine inhibited HepG2 cell proliferation, and Western blot indicated oxymatrine reduced EGFR expression.\"}]","Unveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient–Target Network Analysis | PDF",1790044849,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/734e12f8be0b6bb9b4a148d7a5943e85.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/308d8b91cf96728c170a35293100fb1b.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/931453cfbfdf456507f7bd231c9e4ab6.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8652a374bdff75956a3083bc58a8f95f.webp",980,1385]